Compromiso renal en gammapatías monoclonales
Ibáñez Moreno, Jairo Andrés; Bacca González, Juliana Maria; Taborda Murillo, Alejandra; Ospina Ospina, Sigifredo; Arias, Luis Fernando.
Rev. esp. patol
; 55(1): 4-11, ene-mar 2022. tab, graf, ilus
Artículo en Español | IBECS (España) | ID: ibc-206765
Documentos relacionados
Complete responses in AL amyloidosis are unequal: the impact of free light chain mass spectrometry in AL amyloidosis.
Value of repeat renal biopsy in the evaluation of AL amyloidosis patients lacking renal response despite of complete hematologic remission: a case report and literature review.
[Analysis of clinical manifestations and prognosis of primary systemic light chain amyloidosis with liver involvement].
Renal AA amyloidosis: presentation, diagnosis, and current therapeutic options: a review.
Immunoglobulin light chain amyloidosis: 2024 update on diagnosis, prognosis, and treatment.
Hepatocyte Growth Factor and Primary Systemic Amyloidosis.
A Case-Based Review of Systemic Amyloidosis and its Cutaneous Findings.
AL amyloidosis: advances in diagnostics and treatment.
How I treat AL amyloidosis.
Birtamimab plus standard of care in light-chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial.